Prediction of axillary lymph node metastases in a screened breast cancer population. South-East Sweden Breast Cancer Group

Acta Oncol. 1994;33(6):603-8. doi: 10.3109/02841869409121769.

Abstract

To define a subgroup of patients, in whom axillary dissection could be omitted, we analysed the frequency of pathologically confirmed lymph node metastases depending on tumour size, hormonal receptors, DNA ploidy, S-phase fraction (SPF), and clinical nodal status among 1,145 patients with stage I-II breast cancer from an area with ongoing screening. Clinical nodal status and tumour size were strongly correlated to pathological nodal status. Also SPF > 10% was strongly correlated to node positivity in univariate analysis. In multivariate analysis there was still a significant correlation among cases with tumour size < or = 20 mm. In conclusion, patients with clinically negative nodal status, and tumour size < or = 20 mm and < or = 10 mm had pathologically positive nodes in 25% and 15% of cases respectively. The addition of SPF did not lower these figures significantly since small tumours with high SPF are few.

MeSH terms

  • Adult
  • Aged
  • Axilla
  • Breast Neoplasms / pathology*
  • Breast Neoplasms / prevention & control*
  • DNA, Neoplasm / analysis
  • Female
  • Humans
  • Logistic Models
  • Lymphatic Metastasis / pathology*
  • Lymphatic Metastasis / prevention & control*
  • Mass Screening
  • Middle Aged
  • Multivariate Analysis
  • Neoplasm Staging
  • Ploidies
  • Predictive Value of Tests
  • Receptors, Estrogen / analysis
  • Receptors, Progesterone / analysis
  • Retrospective Studies
  • S Phase

Substances

  • DNA, Neoplasm
  • Receptors, Estrogen
  • Receptors, Progesterone